EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery

Do-Yoon Kang, Sang-Hyup Lee, Se-Whan Lee, Cheol Hyun Lee, Choongki Kim, Ji-Yong Jang, Nihar Mehta, Jun-Hyok Oh, Young Rak Cho, Kyung Ho Yoon, Sung Gyun Ahn, Jung-Hee Lee und 29 weitere

Journal of the American College of Cardiology · 2024

DOI: 10.1016/j.jacc.2024.08.024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von Do-Yoon Kang und 40 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Aspirin, Drug-Eluting Stents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Current guidelines recommend the perioperative continuation of aspirin in patients with coronary drug-eluting stents (DES) undergoing noncardiac surgery. However, supporting evidence is limited. OBJECTIVES: This study aimed to compare continuing aspirin monotherapy vs temporarily holding all antiplatelet therapy before noncardiac surgery in patients with previous DES implantation. METHODS: We randomly assigned patients who had received a DES >1 year previously and were undergoing elective noncardiac surgery either to continue aspirin or to discontinue all antiplatelet agents 5 days before noncardiac surgery. Antiplatelet therapy was recommended to be resumed no later than 48 hours after surgery, unless contraindicated. The primary outcome was a composite of death from any cause, myocardial infarction, stent thrombosis, or stroke between 5 days before and 30 days after noncardiac surgery. RESULTS: A total of 1,010 patients underwent randomization. Among 926 patients in the modified intention-to-treat population (462 patients in aspirin monotherapy group and 464 patients in the no-antiplatelet therapy group), the primary composite outcome occurred in 3 patients (0.6%) in the aspirin monotherapy group and 4 patients (0.9%) in the no antiplatelet group (difference, -0.2 percentage points; 95% CI: -1.3 to 0.9; P > 0.99). There was no stent thrombosis in either group. The incidence of major bleeding did not differ significantly between groups (6.5% vs 5.2%; P = 0.39), whereas minor bleeding was significantly more frequent in the aspirin group (14.9% vs 10.1%; P = 0.027). CONCLUSIONS: Among patients undergoing low-to-intermediate risk noncardiac surgery >1 year after stent implantation primarily with a DES, in the setting of lower-than-expected event rates, we failed to identify a significant difference between perioperative aspirin monotherapy and no antiplatelet therapy with respect to ischemic outcomes or major bleeding. (Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery [ASSURE-DES]; NCT02797548).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsAspirinDrug-Eluting StentsHumansMaleFemaleAgedMiddle AgedSurgical Procedures, OperativeElective Surgical ProceduresPostoperative Complications

Stichwörter der Autor:innen

antiplatelet therapyaspirincoronary artery diseasedrug-eluting stentnoncardiac surgery

Substanzen

Platelet Aggregation InhibitorsAspirin

Autor:innen und Institutionen

  • Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Division of Cardiology, Severance Hospital, Seoul, Korea.
  • Pyeongtaek St Mary's Hospital, Pyeongtaek, Korea.
  • Division of Cardiology, Keimyung University Dongsan Hospital, Daegu, Korea.
  • Division of Cardiology, Ewha Womans University Seoul Hospital, Seoul, Korea.
  • Division of Cardiology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.

Zitieren

APA

Kang, D. Y., Lee, S. H., Lee, S. W., Lee, C. H., Kim, C., Jang, J. Y., Mehta, N., Oh, J. H., Cho, Y. R., Yoon, K. H., Ahn, S. G., Lee, J. H., Cho, D. K., Kim, Y., Kim, J., Cho, G. H., Lee, K. S., Park, H., Vural, M., …, & ASSURE DES Investigators (2024). Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.08.024

Vancouver

Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, et al. Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.08.024

BibTeX
@article{Kang2024,
  author = {Kang, Do-Yoon and Lee, Sang-Hyup and Lee, Se-Whan and Lee, Cheol Hyun and Kim, Choongki and Jang, Ji-Yong and Mehta, Nihar and Oh, Jun-Hyok and Cho, Young Rak and Yoon, Kyung Ho and Ahn, Sung Gyun and Lee, Jung-Hee and Cho, Deok-Kyu and Kim, Yongcheol and Kim, Jeongsu and Cho, Gyeong Hun and Lee, Kyu-Sup and Park, Hanbit and Vural, Mutlu and Lim, Young-Hyo and Park, Kyoung-Ha and Lee, Bong-Ki and Lee, Jong-Young and Park, Hyun-Woo and Yoon, Yong-Hoon and Lee, Jae-Hwan and Lee, Seung-Yul and Park, Kyung Woo and Kang, Jeehoon and Kim, Hyun Kuk and Kang, Si-Hyuck and Park, Jae-Hyoung and Choi, In-Cheol and Yu, Chang Sik and Yun, Sung-Cheol and Park, Duk-Woo and Hong, Myeong-Ki and Park, Seung-Jung and Kim, Jung-Sun and Ahn, Jung-Min and ASSURE DES Investigators, ASSURE DES Investigators},
  title = {Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  doi = {10.1016/j.jacc.2024.08.024}
}
Kostenlos starten →